Cargando…
Considerations in the Management of Hepatitis C Virus-related Thrombocytopenia with Eltrombopag
Thrombocytopenia is a common clinical problem in HCV-infected cases. Multiple studies have consistently shown a rise in platelet count following a successful HCV treatment thus proving a cause-effect relationship between the two. Although, many therapeutic strategies have been tried in the past to t...
Autores principales: | Danish, Fazal A., Koul, Salman S., Subhani, Fazal R., Rabbani, Ahmed E., Yasmin, Saeeda |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023106/ https://www.ncbi.nlm.nih.gov/pubmed/20065578 http://dx.doi.org/10.4103/1319-3767.58772 |
Ejemplares similares
-
Role of Hematopoietic Growth Factors as Adjuncts in the Treatment of Chronic Hepatitis C Patients
por: Danish, Fazal A., et al.
Publicado: (2008) -
Managing HCV Infection in Pediatric Age Group: Suggested Recommendations
por: Danish, Fazal A., et al.
Publicado: (2010) -
Antiviral Therapy in HCV-infected Decompensated Cirrhotics
por: Danish, Fazal A., et al.
Publicado: (2010) -
The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
por: Danish, Fazal-i-Akbar, et al.
Publicado: (2013) -
Managing HCV/HIV coinfection
por: Danish, Fazal A., et al.
Publicado: (2009)